Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebido and Exercise in Older Men With Hypogonadism
NCT01092858Phase 4Terminated
- Sponsor
- Bayer
- Start
- Sep 2010
- Primary completion
- Jul 2011
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Hypogonadism comparing Nebido + Exercise with Placebo + Exercise (2 arms). Primary endpoint: Dynamic maximum strength - one repetition maximum at 54 weeks. Started Sep 2010; status: terminated.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01092858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092858.